Refine my results

Dually Active HIV/HBV Antiretrovirals as Protection Against Incident Hepatitis B Infections: Potential for Prophylaxis

Shilaih, Mohaned

In: Journal of Infectious Diseases, ///-

HIV-1 subtype C, tenofovir, and the relationship with treatment failure and drug resistance

Günthard, Huldrych F.

In: Journal of Infectious Diseases, ///-

The Swiss Transplant Cohort Study: Lessons from the First 6Years

Berger, Christoph ; Bochud, Pierre-Yves ; Boggian, Katja ; Cusini, Alexia ; Egli, Adrian ; Garzoni, Christian ; Hirsch, Hans ; Hoffmann, Matthias ; Khanna, Nina ; Manuel, Oriol ; Meylan, Pascal ; Nadal, David ; van Delden, Christian ; Weisser, Maja ; Mueller, Nicolas

In: Current Infectious Disease Reports, 2015, vol. 17, no. 6, p. 1-5

Using dried blood spots to facilitate therapeutic drug monitoring of antiretroviral drugs in resource-poor regions

Duthaler, Urs ; Berger, Benjamin ; Erb, Stefan ; Battegay, Manuel ; Letang, Emili ; Gaugler, Stefan ; Natamatungiro, Alex ; Mnzava, Dorcas ; Donzelli, Massimiliano ; Krähenbühl, Stephan ; Haschke, Manuel

In: Journal of Antimicrobial Chemotherapy, 2018, vol. 73, no. 10, p. 2729-2737

Selective ß2-adrenoceptor agonists and relevant hyperlactatemia : systematic review and meta-analysis

Liedtke, Alina G. ; Lava, Sebastiano A. G. ; Milani, Gregorio P. ; Agostoni, Carlo ; Gilardi, Viola ; Bianchetti, Mario G. ; Treglia, Giorgio ; Faré, Pietro B.

In: Journal of clinical medicine, 2020, vol. 9, no. 1, p. 71

Selective ß2-agonists have been imputed as potential cause of l-hyperlactatemia since the 1970s. To document the prevalence of hyperlactatemia associated with selective ß2-agonists and to investigate the predisposing factors, we searched for published articles until April 2019 pertaining to the interplay of administration of selective ß2-agonists and circulating l-lactic acid in the Excerpta...

Starting or Changing Therapy - A Prospective Study Exploring Antiretroviral Decision-Making

Fehr, J. ; Nicca, D. ; Sendi, P. ; Wolf, E. ; Wagels, T. ; Kiss, A. ; Bregenzer, T. ; Vernazza, P. ; Jäger, H. ; Spirig, R. ; Battegay, M.

In: Infection, 2005, vol. 33, no. 4, p. 249-256

Effect of Antiretroviral Therapy on Apoptosis Markers and Morphology in Peripheral Lymph Nodes of HIV-Infected Individuals

Ehrhard, S. ; Wernli, M. ; Kaufmann, G. ; Pantaleo, G. ; Rizzardi, G. ; Gudat, F. ; Erb, P. ; Battegay, M.

In: Infection, 2008, vol. 36, no. 2, p. 120-129

Long-term HIV infection and antiretroviral therapy are associated with bone microstructure alterations in premenopausal women

Calmy, A. ; Chevalley, T. ; Delhumeau, C. ; Toutous-Trellu, L. ; Spycher-Elbes, R. ; Ratib, O. ; Zawadynski, S. ; Rizzoli, R.

In: Osteoporosis International, 2013, vol. 24, no. 6, p. 1843-1852

Outcomes of Antiretroviral Therapy in the Swiss HIV Cohort Study: Latent Class Analysis

Keiser, Olivia ; Spycher, Ben ; Rauch, Andri ; Calmy, Alexandra ; Cavassini, Matthias ; Glass, Tracy ; Nicca, Dunja ; Ledergerber, Bruno ; Egger, Matthias

In: AIDS and Behavior, 2012, vol. 16, no. 2, p. 245-255

Variations of CYP3A activity induced by antiretroviral treatment in HIV-1 infected patients

Fellay, Jacques ; Marzolini, Catia ; Decosterd, Laurent ; Golay, Kerry ; Baumann, Pierre ; Buclin, Thierry ; Telenti, Amalio ; Eap, Chin

In: European Journal of Clinical Pharmacology, 2005, vol. 60, no. 12, p. 865-873